Improved treatments of basal cell carcinoma (BCC) represent one of the ... has suggested the possibility of treating these locally advanced or metastatic BCCs with drugs that act specifically ...
Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Penile Cancer.
Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Colorectal Cancer.
People taking metformin had a significantly lower risk of basal cell cancer and a significantly lower risk of squamous cell cancer, results show. “This study strengthens the evidence supporting ...
Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer ...
advanced squamous cell carcinoma (SCC), advanced basal cell carcinoma (BCC), advanced cutaneous squamous cell carcinoma (CSCC), and advanced non-small cell lung cancer (NSCLC). Last week ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Ameluz is a topical currently indicated for the ...
SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation ...
Regeneron announces adjuvant Libtayo significantly improves DFS after surgery in high-risk CSCC in phase 3 trial: Tarrytown, New York Wednesday, January 15, 2025, 11:00 Hrs [IST] ...
Regeneron recently presented five-years results from the phase 3 EMPOWER-Lung 1 trial of Libtayo as a first-line treatment ...